Hep-G2 cells and primary rat hepatocytes differ in their response to inhibitors of HMG-CoA reductase
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 170 (2) , 726-734
- https://doi.org/10.1016/0006-291x(90)92151-o
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Inhibition of cholesterol synthesis by lovastatin tested on six human cell typesin vitroLipids, 1990
- Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acidsThe FASEB Journal, 1990
- A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductaseJournal of Medicinal Chemistry, 1989
- Discovery, biochemistry and biology of lovastatinThe American Journal of Cardiology, 1988
- Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activityBiochemical Journal, 1987
- The isolation of functionally heterogeneous hepatocytes of the proximal and distal half of the liver acinus in the ratHepatology, 1986
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Regulation of low-density lipoprotein receptors in the human hepatoma cell line Hep G2Experimental Cell Research, 1984
- Regulation of Low Density Lipoprotein Receptor Function in a Human Hepatoma Cell LineHepatology, 1984
- Characterization of the major apolipoproteins secreted by two human hepatoma cell linesBiochemistry, 1981